Objective: To collect and identify the environmental bacteria in clean rooms, and to provide data for the investigation and analysis of the results of exceeding the standard, traceability analysis of drug-detecting bacteria and establishment and analysis of clean environmental bacteria database. Methods: Settling bacteria, plankton bacteria and surface microorganisms were collected in clean laboratories, operators and other monitoring points, and the identification and clarification were carried out by using the VITEK2 compact identification system. Results: A total of 53 bacterial isolations were identified from the controlled environment. The isolation ratios of Bacillus spp., Kocuria spp. and Staphylococcus spp. in total isolations were 17.0%, 15.1% and 13.2%, respectively after analysis of different cleanness levels and microbial species. Conclusion: Basic knowledge about the environmental microorganism composition in clean rooms was gained, and the database of environmental microbiology in clean rooms was preliminarily established. It is suggested that pharmaceutical enterprises should control the number of personnel in the clean areas, standardize the personnel's dressing procedures and clean area behavior, formulate effective cleaning and disinfection procedures, strengthen environmental monitoring, regularly analyze monitoring data, study datum trends and take measures in time to deal with abnormal data so as to keep the clean areas in a good state of control.
Key words
clean rooms; environmental bacteria; VITEK2 compact identification system
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 周爽,钱文静.FTIR法用于药品微生物洁净室环境菌库的建立[J].中国卫生产业,2018,1:15-127.
[2] 范一灵,冯震,钟玮,等.无菌药品生产企业核心区微生物污染调查与分析[J].中国药事,2014,28(6):586-590.
[3] 池王胄,宋庭,周芳芳,等.微生物鉴定技术在无菌药品生产企业中的应用[J].中国医药导刊,2012,14(1):169-170.
[4] Sandle T.A Review of Cleanroom Microflora:Types,Trends,and Patterns[J].PDA Journal of Pharmaceutical Science and Technology,2011,65(4):392-403.
[5] 美国药典委员会.美国药典[S].35版.华盛顿:美国药典委员会,2012:886.
[6] 国家药典委员会.中华人民共和国药典:二部[S].北京:中国医药科技出版社,2019:411.
[7] 刘亚茹,余萌,肖璜,等.五家制药企业洁净区微生物群落分析[J].中国药事,2019,7(33):796-802.
[8] 刘卫德,刘绪平,熊骏,等.无菌药品生产企业核心区微生物污染调查与分析[J].中国医药工业杂志,2019,50(11):1335-1340.
[9] 范一灵,房蕊,蒋波,等.微生物鉴定分型技术应用于医药企业微生物污染调查[J].中国医药工业杂志,2010,41(11):810-818.
[10] Clarridge JE.Impact of 16S rRNA Gene Sequence Analysis for Identification of Bacteria on Clinical Microbiology and Infectious Diseases[J].Clin Microbiol Rev,2004,17(4):840-862.
[11] Janda JM,Abbott SL.16S rRNA Gene Sequencing for Bacterial Identification in the Diagnostic Laboratory:Pluses,Perils,and Pitfalls[J].J Clin Microbiol,2007,45(9):2761-2764.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}